1. Home
  2. CYPH vs AMTD Comparison

CYPH vs AMTD Comparison

Compare CYPH & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$1.16

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

HOLD

Current Price

$0.81

Market Cap

71.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
AMTD
Founded
2011
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
71.2M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
CYPH
AMTD
Price
$1.16
$0.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
10.4K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
103.87
N/A
EPS
N/A
N/A
Revenue
$1,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.31
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.71
52 Week High
$3.70
$1.65

Technical Indicators

Market Signals
Indicator
CYPH
AMTD
Relative Strength Index (RSI) 79.45 41.66
Support Level $1.10 $0.71
Resistance Level $1.32 $0.80
Average True Range (ATR) 0.09 0.04
MACD 0.05 0.01
Stochastic Oscillator 82.88 35.71

Price Performance

Historical Comparison
CYPH
AMTD

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.

Share on Social Networks: